SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1052)10/24/2001 10:25:45 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 1475
 
The more space that Gambro occupies as the "whole cell interface" with biotechs, the better. This one is sort of fun, as Dendreon was BTRN's original partner for the function now filled (and expanded upon) by Eligix...........

Wednesday October 24, 10:09 am Eastern Time

Press Release

SOURCE: Gambro

Dendreon Corporation and Gambro Team Up for U.S.
Cell Collection Network for Commercialization of
Cancer Vaccine Therapy (snip)